TIL
NSCInstil Bio Inc.
Professional, Scientific, and Technical Services•Research and Development in Biotechnology
Watchlists:
Last updated: Monday 21st July 2025
26.10
-1.60 (-5.78%)
Prev Close:27.7
Open:27.69
Bid:26.1
Ask:27.25
52 Week Range
9.8592.00
Volume:340,596
Mkt Cap:157 M
40
MarketXLS Rank ®
Hold
Price Target
$30.02
+15.0%
Financial Statements
TIL - Cash Flow (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Invalid date | |
|---|---|---|---|---|---|
| Asset Impairment Charge | 5 M | 68 M | 18 M | ||
| Capital Expenditure Reported | 21 M | 85 M | 58 M | ||
| Cash Flow From Continuing Investing Activities | 54 M | 41 M | 115 M | -474 M | |
| Change In Account Payable | -556000.0 | -1 M | -2 M | 4 M | |
| Change In Payables And Accrued Expense | -556000.0 | -1 M | -2 M | 4 M | |
| Change In Prepaid Assets | -221000.0 | -241000.0 | -430000.0 | -5 M | |
| Change In Working Capital | -9 M | 161000.0 | 5 M | -8 M | |
| Depreciation And Amortization | 4 M | 5 M | 8 M | 3 M | |
| Financing Cash Flow | 2 M | 8 M | 72 M | 393 M | |
| Gain Loss On Sale Of PPE | 343000.0 | 377000.0 | |||
| Interest Paid Supplemental Data | 8 M | 7 M | 1 M | ||
| Issuance Of Capital Stock | 339 M | ||||
| Issuance Of Debt | 1 M | 8 M | 70 M | ||
| Net Business Purchase And Sale | -14 M | -3 M | -3 M | 294000.0 | |
| Net Common Stock Issuance | 339 M | ||||
| Net Foreign Currency Exchange Gain Loss | 275000.0 | -680000.0 | 1 M | 710000.0 | |
| Net Investment Properties Purchase And Sale | 63 M | 60 M | 199 M | -417 M | |
| Net Investment Purchase And Sale | 63 M | 60 M | 199 M | -417 M | |
| Net Issuance Payments Of Debt | 1 M | 8 M | 70 M | ||
| Net Long Term Debt Issuance | -83 M | -587000.0 | |||
| Net PPE Purchase And Sale | 866000.0 | -19 M | -85 M | -58 M | |
| Net Preferred Stock Issuance | 52 M | ||||
| Other Non-cash Items | 27 M | 73 M | 32 M | 39 M | |
| Preferred Stock Issuance | 52 M | ||||
| Proceeds From Stock Option Exercised | 365000.0 | 2 M | 2 M | ||
| Purchase Of Investment | -136 M | -301 M | -666 M | -1,108 M | |
| Purchase Of Long Term Investments | -2 M | -1 M | |||
| Purchase Of PPE | -21 M | -85 M | -58 M | ||
| Repayment Of Debt | -84 M | -587000.0 | |||
| Sale Of Business | -4 M | -3 M | -3 M | 294000.0 | |
| Sale Of Investment | 198 M | 362 M | 865 M | 691 M | |
| Sale Of PPE | 866000.0 | 2 M | |||
| Short Term Debt Issuance | 86 M | 9 M | 70 M | ||
| Short Term Debt Payments | -1 M | -587000.0 | |||
| Stock Based Compensation | 17 M | 18 M | 30 M | 26 M | |
| Unrealized Gain Loss On Investment Securities | 1 M | 1 M | -1 M | ||
| Amord | 640000.0 | 2 M | |||
| Begcash | 38 M | 242 M | |||
| Capex | 866000.0 | -19 M | -85 M | -58 M | |
| Cffcf | 2 M | 8 M | 72 M | 393 M | |
| Cffinv | 54 M | 41 M | 115 M | -474 M | |
| Cffoa | -56 M | -82 M | -177 M | -122 M | |
| Chgcash | 33000.0 | -33 M | 6 M | -203 M | |
| Chgothcl | -2 M | 5 M | |||
| Chgothwc | -9 M | 2 M | 2 M | -7 M | |
| Chgpay | -556000.0 | -1 M | -2 M | 4 M | |
| Comstkiss | 339 M | ||||
| Depamor | 4 M | 5 M | 6 M | 3 M | |
| Effexch | -94000.0 | -201000.0 | -637000.0 | ||
| Endcash | 11 M | -33 M | 44 M | 38 M | |
| Fcf | -56 M | -101 M | -265 M | -180 M | |
| Ltdebtpay | -83 M | -587000.0 | |||
| Netinccont | -74 M | -156 M | -223 M | -157 M | |
| Netothfin | -69000.0 | ||||
| Netothinv | 605000.0 | ||||
| Netstdebtiss | 84 M | 9 M | 70 M | ||
| Opcf | -56 M | -82 M | -180 M | -122 M | |
| Opgainloss | 1 M | -303000.0 | 1 M | 710000.0 | |
| Purchbus | -10 M | ||||
| Purchsti | -134 M | -301 M | -665 M | -1,108 M | |
| Salesti | 198 M | 362 M | 865 M | 691 M |